The gaps were impossible to unsee
As a practicing physician, I saw firsthand the gaps in our healthcare system. Patients struggled to access quality medications at affordable prices. Clinical trials were slow and inefficient. The disconnect between clinical care and healthcare innovation was striking.
My time at Cerner / Oracle Health as Chief Medical Informatics Officer taught me how technology could transform healthcare delivery. But I wanted to do more than advise from the sidelines — I wanted to build solutions that would directly impact patient lives.
That's why I founded ThinkRoman Ventures: a platform where my clinical experience could fuel healthcare innovation. It was never about starting one company. It was about building an ecosystem where many healthcare solutions could flourish.
The opportune moment
Clinical research is the backbone of medical progress, yet the process was plagued by inefficiencies. Patient recruitment took forever. Documentation was a nightmare. Smaller sponsors struggled to compete.
Kairos R&D Solutions was my answer — a CRO that leverages AI for patient matching, streamlines documents through Kairodox, and makes research accessible to sponsors of every size.
The name “Kairos” is Greek for the opportune moment — the perfect time to act. In clinical research, timing is everything. We help our partners seize it.
Medicine by someone who prescribes it
In my years of practice, I prescribed antibiotics countless times. I knew which ones worked best and which ones patients struggled to afford. The gap between quality and accessibility troubled me.
TrPharma was born from that frustration — a pharmaceutical division that combines clinical knowledge with manufacturing excellence. KashMOX 625 became our flagship: a WHO-GMP certified Amoxicillin-Clavulanate antibiotic with the efficacy of premium brands at an accessible price.
We followed with One87 Plus for pain management and KashCAL Plus for bone health — each developed with the same physician-first approach.
Doctor-led innovation
Healthcare innovation should be led by people who understand patient care at its core — not from business cases or market research, but from years of sitting with patients, understanding their fears, and witnessing their recoveries.
Every decision runs through one question: “Would I prescribe this to my own family?”